Cargando…

Single step method for high yield human platelet lysate production

BACKGROUND: We aimed to develop a single step method for the production of human platelet lysate (hPL). The method must result in high hPL yields, be closed system and avoid heparin use. STUDY DESIGN AND METHODS: The method aimed at using glass beads and calcium. An optimal concentration of calcium...

Descripción completa

Detalles Bibliográficos
Autores principales: Delabie, Willem, De Bleser, Dominique, Vandewalle, Vicky, Vandekerckhove, Philippe, Compernolle, Veerle, Feys, Hendrik B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099704/
https://www.ncbi.nlm.nih.gov/pubmed/36426732
http://dx.doi.org/10.1111/trf.17188
_version_ 1785025111529619456
author Delabie, Willem
De Bleser, Dominique
Vandewalle, Vicky
Vandekerckhove, Philippe
Compernolle, Veerle
Feys, Hendrik B.
author_facet Delabie, Willem
De Bleser, Dominique
Vandewalle, Vicky
Vandekerckhove, Philippe
Compernolle, Veerle
Feys, Hendrik B.
author_sort Delabie, Willem
collection PubMed
description BACKGROUND: We aimed to develop a single step method for the production of human platelet lysate (hPL). The method must result in high hPL yields, be closed system and avoid heparin use. STUDY DESIGN AND METHODS: The method aimed at using glass beads and calcium. An optimal concentration of calcium and glass beads was determined by serial dilution. This was translated to a novel method and compared to known methods: freeze‐thawing and high calcium. Quality outcome measures were transmittance, fibrinogen and growth factor content, and cell doubling time. RESULTS: An optimal concentration of 5 mM Ca(2+) and 0.2 g/ml glass beads resulted in hPL with yields of 92% ± 1% (n = 50) independent of source material (apheresis or buffy coat‐derived). The transmittance was highest (56% ± 9%) compared to known methods (<39%). The fibrinogen concentration (7.0 ± 1.1 μg/ml) was well below the threshold, avoiding the need for heparin. Growth factor content was similar across hPL production methods. The cell doubling time of adipose derived stem cells was 25 ± 1 h and not different across methods. Batch consistency was determined across six batches of hPL (each n = 25 constituting concentrates) and was <11% for all parameters including cell doubling time. Calcium precipitation formed after 4 days of culturing stem cells in media with hPL prepared by the high (15 mM) Ca(2+) method, but not with hPL prepared by glass bead method. DISCUSSION: The novel method transforms platelet concentrates to hPL with little hands‐on time. The method results in high yield, is closed system, without heparin and non‐inferior to published methods.
format Online
Article
Text
id pubmed-10099704
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-100997042023-04-14 Single step method for high yield human platelet lysate production Delabie, Willem De Bleser, Dominique Vandewalle, Vicky Vandekerckhove, Philippe Compernolle, Veerle Feys, Hendrik B. Transfusion Cellular Therapies BACKGROUND: We aimed to develop a single step method for the production of human platelet lysate (hPL). The method must result in high hPL yields, be closed system and avoid heparin use. STUDY DESIGN AND METHODS: The method aimed at using glass beads and calcium. An optimal concentration of calcium and glass beads was determined by serial dilution. This was translated to a novel method and compared to known methods: freeze‐thawing and high calcium. Quality outcome measures were transmittance, fibrinogen and growth factor content, and cell doubling time. RESULTS: An optimal concentration of 5 mM Ca(2+) and 0.2 g/ml glass beads resulted in hPL with yields of 92% ± 1% (n = 50) independent of source material (apheresis or buffy coat‐derived). The transmittance was highest (56% ± 9%) compared to known methods (<39%). The fibrinogen concentration (7.0 ± 1.1 μg/ml) was well below the threshold, avoiding the need for heparin. Growth factor content was similar across hPL production methods. The cell doubling time of adipose derived stem cells was 25 ± 1 h and not different across methods. Batch consistency was determined across six batches of hPL (each n = 25 constituting concentrates) and was <11% for all parameters including cell doubling time. Calcium precipitation formed after 4 days of culturing stem cells in media with hPL prepared by the high (15 mM) Ca(2+) method, but not with hPL prepared by glass bead method. DISCUSSION: The novel method transforms platelet concentrates to hPL with little hands‐on time. The method results in high yield, is closed system, without heparin and non‐inferior to published methods. John Wiley & Sons, Inc. 2022-11-25 2023-02 /pmc/articles/PMC10099704/ /pubmed/36426732 http://dx.doi.org/10.1111/trf.17188 Text en © 2022 The Authors. Transfusion published by Wiley Periodicals LLC on behalf of AABB. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Cellular Therapies
Delabie, Willem
De Bleser, Dominique
Vandewalle, Vicky
Vandekerckhove, Philippe
Compernolle, Veerle
Feys, Hendrik B.
Single step method for high yield human platelet lysate production
title Single step method for high yield human platelet lysate production
title_full Single step method for high yield human platelet lysate production
title_fullStr Single step method for high yield human platelet lysate production
title_full_unstemmed Single step method for high yield human platelet lysate production
title_short Single step method for high yield human platelet lysate production
title_sort single step method for high yield human platelet lysate production
topic Cellular Therapies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099704/
https://www.ncbi.nlm.nih.gov/pubmed/36426732
http://dx.doi.org/10.1111/trf.17188
work_keys_str_mv AT delabiewillem singlestepmethodforhighyieldhumanplateletlysateproduction
AT debleserdominique singlestepmethodforhighyieldhumanplateletlysateproduction
AT vandewallevicky singlestepmethodforhighyieldhumanplateletlysateproduction
AT vandekerckhovephilippe singlestepmethodforhighyieldhumanplateletlysateproduction
AT compernolleveerle singlestepmethodforhighyieldhumanplateletlysateproduction
AT feyshendrikb singlestepmethodforhighyieldhumanplateletlysateproduction